Status:
UNKNOWN
Glycemic Variability, Gut Microbiota, and Prognosis in T2DM With ACS
Lead Sponsor:
Second Affiliated Hospital of Nanchang University
Conditions:
Type 2 Diabetes Mellitus
Coronary Heart Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Patients with type 2 diabetes mellitus (T2DM) diagnosed with acute coronary syndrome (ACS) by coronary angiography in the Second Affiliated Hospital of Nanchang University were consecutively included ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Type 2 Diabetes Mellitus (T2DM).
- Clinical diagnosis of Acute Coronary Syndrome (ACS).
Exclusion
- History of hemodialysis.
- Recent antibiotic use within the past two weeks.
- Active malignant tumors.
- Pregnancy and breastfeeding.
- Inability to wear sensors due to severe skin conditions.
- Coagulation disorders, anemia, or abnormal hematocrit levels.
- Requirement for MRI during the sensor-wearing period.
- Inability to follow study instructions or deemed unsuitable for the trial by the treating clinician/nurse.
- Inability to understand informed consent or communicate with researchers due to cognitive decline or mental illness.
Key Trial Info
Start Date :
July 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06573060
Start Date
July 5 2023
End Date
September 30 2025
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital Of Nanchang University
Nanchang, Jiangxi, China, 330000